Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French agree on home dialysis rates:

This article was originally published in Clinica

Executive Summary

Following agreement with two industry associations focused on providing healthcare in the home, the French health ministry has issued a notice relating to the price and reimbursement levels for ambulatory dialysis equipment. The national healthcare products economics committee has entered into a contract with trade associations, Synalam and Snadom, which set a maximum price before tax for the sale to distributors that then sell directly to those insured socially. The maximum price for a programmable ambulatory insulin perfusion pump is E2,600 ($3,300), and the maximum price for a catheter and associated accessories is E17.53. The agreement also extends to the reimbursement price for each use of such a system, for monthly loans of the equipment, and to training costs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052886

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel